Learn about SurVeil Drug Coated Balloon (DCB) for treatment of stenotic peripheral arteries (PAD) through mechanical dilatation & microcrystalline paclitaxel delivery.

This comprehensive review focuses on drug-coated balloon technology as a tool to treat peripheral artery disease and the effects of the molecular mechanisms involved in preventing vascular restenosis.

Jul 11, 2023 · Paclitaxel-coated balloons and paclitaxel-eluting stents are intended to treat both new and recurring atherosclerotic lesions in the femoropopliteal artery (located in the upper leg). The...

The FDA-approved Lutonix® 035 drug-coated balloon (DCB) is used to re-open arteries in the thigh (superficial femoral arteries) and knee (popliteal arteries) when narrowed or blocked as a result of PVD.

Two newer devices, drug-eluting stents and drug-eluting balloons, are on the forefront of the battle against limb loss from PAD. This review focuses on the data backing the use of drug-eluting technologies for use in the peripheral arterial system. Keywords: peripheral artery disease, atherosclerosis, paclitaxel, interventional radiology.

Sep 15, 2015 · In this year, three major pivotal trials have confirmed the safety and efficacy of paclitaxel-coated balloons in the endovascular treatment of femoropopliteal artery disease.

Background: The relative merits of the drug-coated balloon (DCB) versus uncoated balloon (UCB) angioplasty in endovascular intervention for patients with symptomatic lower extremity peripheral arterial disease (PAD) remains controversial.

Peripheral Cutting Balloon (PCB) is designed to minimize vessel trauma with its unique mechanism of action. The C-code used for this product is C1725, catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability). C-codes are used for hospital outpatient device reporting for Medicare and some private payers.

The Armada™ 14 XT PTA Catheter is indicated to dilate stenosis in femoral, popliteal, infrapopliteal and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The 2.0 mm to 5.0 mm balloon diameters are also indicated for post-dilatation of stents in the peripheral vasculature.

Balloon angioplasty of the peripheral arteries is the most common technique, and numerous balloons are available (see Table 1, p. 43). The recent trend in peripheral dilatation balloons has been to decrease the crossing profile and decrease maximum guidewire compatibility.